Entering text into the input field will update the search result below

Acadia Pharmaceuticals (NASDAQ:ACAD): Q4 EPS of ($0.10) in line. Revenue of $588K beats by $38K....

Mar. 06, 2012 4:16 PM ETACADIA Pharmaceuticals Inc. (ACAD) StockACADBy: David Yelle, SA News Editor
Acadia Pharmaceuticals (NASDAQ:ACAD): Q4 EPS of ($0.10) in line. Revenue of $588K beats by $38K. (PR)

Recommended For You

More Trending News

About ACAD Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ACAD--
ACADIA Pharmaceuticals Inc.